Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026)
Johnson & Johnson (JNJ) posted Exchange Rate Effect of -$25.0 million for Q1 2026, down 208.7% sequentially from $23.0 million in Q4 2025, and down 135.71% YoY from $70.0 million in Q1 2025.
Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 18 years of Exchange Rate Effect data on file, last reported at -$25.0 million in Q1 2026.
- Quarterly Exchange Rate Effect fell 135.71% year-over-year to -$25.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.0 million (up 212.77% YoY) and the FY2025 annual result came in at $201.0 million, up 169.55% from the prior year.
- Exchange Rate Effect fell to -$25.0 million in Q1 2026 per JNJ's latest filing, from $23.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $154.0 million in Q2 2025, with the low at -$198.0 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is -$26.4 million, with a median of -$25.0 million recorded in 2026.
- Year-over-year, Exchange Rate Effect tumbled 546.43% in 2024 and surged 281.18% in 2025.
- Johnson & Johnson's Exchange Rate Effect stood at $16.0 million in 2022, then jumped by 681.25% to $125.0 million in 2023, then tumbled by 258.4% to -$198.0 million in 2024, then jumped by 111.62% to $23.0 million in 2025, then sank by 208.7% to -$25.0 million in 2026.
- Business Quant data shows JNJ's Exchange Rate Effect at -$25.0 million in Q1 2026, $23.0 million in Q4 2025, and -$46.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 67.00 Mn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | -25.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -12.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -18.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -77.00 Mn |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | -18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -25.00 Mn |
| Mar 29, 2026 | -25.00 Mn |
| Dec 28, 2025 | 23.00 Mn |
| Dec 28, 2025 | 23.00 Mn |
| Sep 28, 2025 | -46.00 Mn |
| Sep 28, 2025 | -46.00 Mn |
| Jun 29, 2025 | 154.00 Mn |
| Jun 29, 2025 | 154.00 Mn |
| Mar 30, 2025 | 70.00 Mn |
| Mar 30, 2025 | 70.00 Mn |
| Dec 29, 2024 | -198.00 Mn |
| Dec 29, 2024 | -198.00 Mn |
| Sep 29, 2024 | 119.00 Mn |
| Sep 29, 2024 | 119.00 Mn |
| Jun 30, 2024 | -85.00 Mn |
| Jun 30, 2024 | -85.00 Mn |
| Mar 31, 2024 | -125.00 Mn |
| Mar 31, 2024 | -125.00 Mn |
| Dec 31, 2023 | 125.00 Mn |
| Dec 31, 2023 | 125.00 Mn |